MedPath

Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG

Not Applicable
Conditions
coronary artery bypass grafting
Registration Number
JPRN-UMIN000030105
Lead Sponsor
HAMAMATSU UNIVERSITY HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
35
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who can not obtain informed consent Patients judged inappropriate by the physician in charge of this study Patients with atrial fibrillation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath